跳至主要内容
临床试验/NCT06283732
NCT06283732已完成不适用

A Clinical Study to Assess the Effect of a Supplement on Digestive Health, Overall Well-being, and Participant Experience.

Amway Corp2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2023年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
70
试验地点
2
主要终点
Digestive Health Improvement

研究概览

简要总结

The study aims to evaluate the effectiveness of a dietary supplement (greens powder), on improving digestive health, quality of life, energy levels, and satiety over a 14-day period. Participants, aged 18-65 and experiencing mild digestive issues, will consume the greens powder daily and report outcomes through diaries and questionnaires.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female.
  • Aged 18-65 years.
  • Willing to comply with study requirements.
  • No known allergies to the ingredients listed in the product.
  • Self-reported mild digestive issues (e.g., occasional bloating, stomach discomfort, occasional constipation, or occasional diarrhea).
  • Generally healthy - do not live with any uncontrolled chronic disease .

排除标准

  • Pre-existing chronic conditions that would prevent adherence to the protocol, including oncological and psychiatric disorders.
  • Known severe allergic reactions that require an Epi-Pen.
  • Women who are pregnant, breastfeeding, or attempting to conceive.
  • History of severe diagnosed digestive disorders (e.g., IBS, IBD, Crohn's disease) or gastrointestinal-tract surgeries.
  • Unwillingness to follow the study protocol.
  • Invasive medical procedure within the last three weeks or planning one during the study period.
  • History of substance abuse.
  • Current participation or planning to participate in another research study.
  • Regular consumption of probiotics, fiber, or prebiotic supplements within 3 weeks of the study.
  • Regular intake of medications that may interfere with the study or study product (e.g., anticoagulants, laxatives, sedatives, beta-blockers, anti-acids) .

结局指标

主要结局

Digestive Health Improvement

时间窗: 14 days from the start of intervention

Measure the change in digestive health using daily diaries and the Bristol Stool Scale (BSS).

次要结局

  • Quality of Life and Well-being Enhancement(14 days from the start of intervention)

研究者

发起方
Amway Corp
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验